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Abstract
Background: Cannabis is the most widely consumed illicit substance in America, with increasing
rates of use. Some theorists tend to link frequency of use with cannabis dependence. Nevertheless,
fewer than half of daily cannabis users meet DSM-IV-TR criteria for cannabis dependence. This
study seeks to determine whether the negative aspects associated with cannabis use can be
explained by a proxy measure of dependence instead of by frequency of use.
Results: Over 2500 adult daily cannabis users completed an Internet survey consisting of measures
of cannabis and other drug use, in addition to measures of commonly reported negative problems
resulting from cannabis use. We compared those who met a proxy measure of DSM-IV-TR criteria
for cannabis dependence (N = 1111) to those who did not meet the criteria (N = 1770). Cannabis
dependent subjects consumed greater amounts of cannabis, alcohol, and a variety of other drugs.
They also had lower levels of motivation, happiness, and satisfaction with life, with higher levels of
depression and respiratory symptoms.
Conclusion: Although all of our subjects reported daily use, only those meeting proxy criteria for
cannabis dependence reported significant associated problems. Our data suggest that dependence
need not arise from daily use, but consuming larger amounts of cannabis and other drugs
undoubtedly increases problems.
Background
More people consume cannabis than any other illicit sub-
stance in America. In 2000, 76 percent of all current illicit
drug users (14 million people) consumed cannabis [1].
Anthony, Warner, and Kessler [2] estimate that cannabis
produces dependence in 9.1 percent of people who ever
use cannabis in their lifetime. Therefore, not all cannabis
users meet the DSM-IV-TR criteria for dependence. The
causes of cannabis dependence remain poorly under-
stood. One theory states that the frequency of cannabis
use is associated with dependence [3,4]. In a study of the
relationship between frequency and quantity of cannabis
use and dependence, frequency of use was shown to be
linearly associated with the probability of dependence
and was a stronger predictor than quantity of use [5]. The
2003 National Survey on Drug Use and Health demon-
strated that only 13.5 percent of non-daily users were can-
nabis-dependent, as compared to 39.2 percent of daily
users [6]. Although daily users in this national survey had
higher rates of dependence, more than half of the subjects
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failed to meet the criteria. Thus, daily use is no guarantee
of dependence.
The quantity of cannabis consumption may determine
dependence. In 450 cannabis users who met the criteria
for dependence, Stephens, Babor, Kadden, Miller, and The
Marijuana Treatment Project Research Group [7] found
that the typical participant smoked cannabis almost daily
and consumed nearly three joints per day and almost half
an ounce of cannabis per week. They also reported getting
high more than four times per day and felt high for
approximately seven hours each day. On average, these
subjects reported experiencing upwards of five depend-
ence symptoms, demonstrating that using larger amounts
of cannabis and feeling high for longer periods may con-
tribute to cannabis dependence.
Comorbid use of alcohol may also increase cannabis
dependence. Frequent or heavy alcohol use in conjunc-
tion with cannabis increases the probability of depend-
ence [8]. Cannabis dependent users are more likely to
meet the criteria for alcohol dependence [9], as well as
report consuming more alcoholic drinks in one sitting
[10]. Bell, Wechsler, and Johnston [11] also observed that
students who were binge drinkers were far more likely to
use cannabis than students who did not binge drink.
Although it is difficult to determine the exact causal rela-
tionship between alcohol and cannabis use, alcohol does
appear to moderate the association between cannabis use
and dependence.
A user's age may also determine dependence. Adolescents,
particularly those with an early onset of cannabis use, are
more susceptible to cannabis dependence [12,13]. Canna-
bis users under the age of 17 are 3.44 times more at risk
for meeting three dependence symptoms than are users
over the age of 26 [14].
In addition to exploring the causes of cannabis depend-
ence, much of the current literature on cannabis has
sought to describe the characteristics of heavy users. Sev-
eral studies have noted an association between cannabis
use and lower educational attainment [15,16]. Fergusson,
Horwood, and Beautrais [17] analyzed a 25-year longitu-
dinal study and demonstrated that at age 16, those who
had used cannabis on more than 100 occasions were
nearly six times as likely to leave school without graduat-
ing as those who had never used cannabis. In the same
sample, students at the age of 20 who had never used can-
nabis were four and a half times more likely to receive a
college degree than students who had used cannabis more
than 100 times. In contrast, Reilly, Didcott, Swift, and
Hall [18] found a sample of long-term Australian canna-
bis users to be well-educated, with 62 percent of the par-
ticipants having obtained higher education after leaving
school.
A correlation has been posited between cannabis use and
lack of motivation and depression. McGlothlin and West
[19] describe an "amotivational syndrome" amongst
heavy cannabis users entailing apathy, loss of effective-
ness, and a diminished ability to concentrate, follow rou-
tines, and successfully master new material. Similarly,
Musty and Kaback [20] detected amotivational symptoms
in a sample of heavy cannabis users, but attributed the
behavior instead to coexisting depressive symptoms.
Research on the affective states of cannabis users has sug-
gested that cannabis abusers are more likely than non-
abusers to report feeling depressed [21] and heavy canna-
bis use may actually increase depressive symptoms [22].
Furthermore, individuals with cannabis dependence are
at greater risk of suicide attempts, perhaps due to a comor-
bid mood disorder [23]. Despite these findings, other
work does not support a link between cannabis use and
depression [24], nor an association between cannabis use
and lack of motivation [25-27].
In addition, both current and heavy users have been
shown to consistently report lower levels of satisfaction
with quality of life than control subjects [28]. Stephens et
al. [7] similarly demonstrated that in a sample of cannabis
dependent individuals, 90 percent felt bad about their use
and almost 75 percent had lowered self-esteem. The
authors speculate that people who seek treatment are pri-
marily motivated by these feelings that stem from
dependence. This result illustrates that many heavy canna-
bis users report a decreased quality of life and well-being.
Finally, cannabis dependent users have been shown to
have a significantly increased likelihood of reporting a
wide range of respiratory symptoms and exhibiting
decreased lung functioning [29]. In a nationally represent-
ative sample of 6728 adults, cannabis use was associated
with a number of problems including bronchitis, cough-
ing, phlegm production, and wheezing, even after con-
trolling for age, tobacco use, and asthma [30]. Given that
only 16 percent of the sample used cannabis on a daily
basis, it is likely that the range of respiratory problems is
even greater in a cannabis dependent population. On the
contrary, Tashkin, Simmons, Sherrill, and Coulson [31]
found no evidence of habitual cannabis use contributing
to decreased lung functioning or chronic obstructive pul-
monary disease.
The current study seeks to examine if the discrepancies
surrounding the research on cannabis use can be resolved
by separating out those users who meet the DSM-IV-TR
criteria for cannabis dependence. We aim to determine
possible links to cannabis dependence and to demon-Substance Abuse Treatment, Prevention, and Policy 2007, 2:3 http://www.substanceabusepolicy.com/content/2/1/3
Page 3 of 7
(page number not for citation purposes)
strate whether dependent cannabis users are more likely
to report these negative aspects of cannabis use than non-
dependent users, even when both groups are daily users.
Methods
Participants
Participants responded to an email request. In an effort to
target frequent cannabis users, three organizations com-
mitted to altering drug laws (The Marijuana Policy
Project, The National Organization for the Reform of Mar-
ijuana Laws, and The Drug Policy Alliance) were asked to
send a query to their mailing lists for participation in a
survey in return for the chance to win a cash prize. Partic-
ipants were also asked to forward the link to their friends.
Approximately 9,000 people replied.
We focus on those who currently used cannabis daily. The
2881 people who qualified included 1842 men (63.9%)
and 1039 women (36.1%). Ages ranged from 18 to 88 (M
= 33.03, SD = 12.72). Education ranged from some high
school to advanced degrees, with a median of some col-
lege without a bachelor's degree. Median income was
$20,000 to $40,000 per year. Respondents were primarily
Caucasian (87%), but included African Americans (1%),
Native Americans (3%), Asians (1%) Latinos (1%), and
people of mixed race (5%). Two percent of participants
preferred not to answer. Those who used cannabis began
at a mean age of 16.8 (SD = 4.3).
Procedure
The protocol and informed consent were approved by a
local Institutional Review Board. Upon beginning the sur-
vey, subjects were informed of the nature of the study and
provided consent. Participants were informed that they
would be responding to questions regarding their drug
use, as well as indices of quality of life. Brief question-
naires were utilized to assess many of our variables of
interest in order to increase response and retention rate.
Cannabis use
Participants reported if they ever used cannabis in their
lifetime. Those who said they had ever used were also
asked if they had used in the previous month. Those who
had used in the previous month were asked how many
days per week they used on average. All participants in this
study reported using 7 days per week. Although estimat-
ing quantity of consumption is difficult for cannabis, they
also reported the number of joints they consumed per
week. Furthermore, participants responded to questions
based on the DSM-IV-TR criteria for substance depend-
ence (see Table 1). These self-reported symptoms served
as a proxy measure for cannabis dependence. Each item
required the participant to respond affirmatively or nega-
tively to a question regarding their experience with a par-
ticular dependence symptom within the past 12 months.
Subjects who endorsed three or more of the 7 items were
considered to be cannabis dependent, as designated by
the DSM-IV-TR criteria for substance dependence [32].
Alcohol consumption
Participants reported their average number of standard
drinks consumed on an occasion and the frequency with
which they drank alcohol per week.
Other drug use
Participants reported the number of tobacco cigarettes
they consumed each day as well as whether or not they
had used any of the following drugs in the last year: inha-
lants, methamphetamine, speed, cocaine, crack cocaine,
ecstasy, psilocybin, LSD, and heroin.
Cannabis associated problems
Participants responded to nineteen questions from the
Marijuana Problems Questionnaire (MPS) regarding
problems associated with their cannabis use in the past 90
days on a six-point scale (i.e. 0 = no problem, 5 = serious
problem) [33]. Examples of included items are: Problems
in your family; Problems between you and your partner;
Missing days at work or class; Withdrawal Symptoms; To
feel bad about your use.
Respiratory symptoms
Six questions appeared based on previous studies of can-
nabis's impact on respiratory symptoms. These included:
Do you usually have a cough? Does your chest sound
wheezy or whistling other than from colds? Are you trou-
Table 1: Proxy cannabis dependence questions
Item
1. Do you use cannabis much more often or in greater amounts than you intended?
2. Did you want to or try to cut down on your cannabis use but find that you could not?
3. Did your cannabis use keep you from going to work or school, or engaging in recreational activities?
4. Have you experienced a month or more of spending a great deal of time getting cannabis, using it, or recovering from its effects?
5. Did cannabis cause you emotional or psychological problems, such as feeling uninterested in things, feeling depressed, feeling suspicious, feeling 
paranoid, or having strange ideas?
6. Have you developed a tolerance to cannabis so that the same amount of drug had less effect than before?
7. Has cannabis caused you to experience withdrawal symptoms?Substance Abuse Treatment, Prevention, and Policy 2007, 2:3 http://www.substanceabusepolicy.com/content/2/1/3
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bled by shortness of breath when hurrying on the level
ground or walking up a slight hill? Do you have to walk
slower than most people your own age on the level
ground because of breathlessness? Do you cough up
phlegm in the morning? Do you wake up at night with
tightness in your chest? [29].
Satisfaction with Life
Participants completed Diener's 5-item Satisfaction With
Life Scale [34]. Internal consistency was .85.
Happiness
Participants completed the Happiness Scale, a 4-item
report of subjective happiness [35]. Internal consistency
was .86
Motivation
Respondents completed items from the Apathy Evalua-
tion Scale (AES) [36]. Participants responded to 12 state-
ments regarding their own feelings of motivation on a
four-point scale (e.g. Not At All; Slightly; Somewhat; Very
Much). Eight items that accounted for the most variance
in the scale were selected. Additional items were added
based on face validity. Items included: I get things done
during the day; getting things done during the day is
important to me; I approach life with intensity; Seeing a
job through to the end is important to me; Getting things
done on my own is important to me; I have initiative; I
have motivation; I set goals for myself; I don't follow
through on my plans (reverse coded); I have some inter-
esting projects I'm working on; I'm pretty productive most
of the time; I am interested in things. The twelve items
possessed sound internal consistency (Cronbach's α
=.82). Similar measures of apathy have been used success-
fully in previous studies of substance use and motivation,
showing increased apathy among the cocaine dependent
[37].
Depression
The Center for Epidemiologic Studies Depression scale
(CES-D) [38], a popular self-report measure designed to
explore depressive symptoms in the general population,
contains 20 items. The CES-D asks respondents to indi-
cate the frequency or duration of specific symptoms asso-
ciated with depression (e.g., "I had crying spells") during
the previous week. Internal consistency was .90.
Results
Of all the participants, 1111 subjects met the criteria for
proxy dependence (DEP), while 1770 subjects were non-
dependent (N-DEP). Missing data was found for many of
the variables of interest. However, given that no more
than 5% of participants failed to respond on each of the
variables, these cases were not removed since they should
not impact our findings and retaining these individuals
will increase our overall power.
Independent samples t-tests revealed that cannabis
dependent individuals (M = 27.895, SD = 10.63), relative
to non-dependent volunteers (M = 36.34, SD = 12.88),
were significantly younger [t (2839) = 18.18; P < .001],
and had fewer years of schooling (DEP: M = 3.43, SD =
1.23; N-DEP: M = 3.59, SD = 1.41), [t (2870) = 3.18; P <
.01]. Table 2 shows that cannabis dependent participants
reported smoking a greater number of joints per week,
using a larger amount of cannabis by quarter ounce per
month, feeling higher on average during cannabis con-
sumption, experiencing a greater maximum high, averag-
ing a greater number of alcoholic drinks per drinking
occasion, and consuming more alcoholic drinks per week
than non-dependent daily users. In addition, Table 2
shows that happiness, satisfaction with life, and motiva-
tion are decreased and depression is increased in depend-
ent individuals. Furthermore, those cannabis dependent
individuals experienced more respiratory and additional
problems associated with cannabis use than did non-
dependent users. Since a large number of subjects con-
sumed tobacco cigarettes in addition to cannabis (DEP: n
= 837; N-DEP: n = 1398), an ANCOVA was performed to
covary out cigarette use. Cannabis dependence continued
to predict respiratory problems, even after cigarettes were
accounted for (F (1, 2879) = 133.68, p < .001). Because
cigarette use was a significant predictor, we are reporting
the covariate corrected means of respiratory symptoms for
the cannabis groups (DEP: M = 1.29, SD = 1.20; N-DEP:
M = .77, SD = 1.18).
Chi-square tests revealed higher use of other illicit drugs
in the dependent group. Table 3 shows that cannabis
dependent subjects were more likely to have used inha-
lants, methamphetamine, speed, cocaine, crack cocaine,
ecstasy, psilocybin, and LSD in the past year than non-
dependent users.
Discussion
We examined how behaviors and problems differed
between dependent and non-dependent daily cannabis
users, using a proxy measure of dependence based upon
the DSM-IV-TR criteria. The findings from this study pro-
vide insight into the inconsistencies seen in the cannabis
literature. Various traits and problems are seen more often
in some cannabis users compared to others, and the data
show that these differences can be attributed to whether
or not the user is cannabis dependent. The results demon-
strate that dependent daily cannabis users are more likely
to be younger and less educated than non-dependent
daily users. Although frequency of use was the same
between the two groups, dependent users consumed a
larger amount of cannabis per week and per month, andSubstance Abuse Treatment, Prevention, and Policy 2007, 2:3 http://www.substanceabusepolicy.com/content/2/1/3
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reported getting higher and achieving a greater maximum
high than non-dependent users. In addition, alcohol con-
sumption differed between the groups, with dependent
users ingesting the greatest number of alcoholic beverages
per occasion and per week. Furthermore, dependent can-
nabis users were more likely to have used a variety of illicit
drugs within the past year than were non-dependent
users.
The two groups also differed on ratings related to mood.
Cannabis dependence was associated with higher levels of
depression, and lower levels of motivation, satisfaction
with life, and happiness. Dependent users additionally
suffered a greater number of respiratory problems, even
when cigarette smoking was accounted for. Finally, canna-
bis dependent individuals more frequently reported addi-
tional cannabis-related problems than did non-
dependent subjects. These results are consistent with find-
ings that cannabis dependent individuals, particularly
those who experience tolerance and withdrawal, are more
likely to self-report problems related to cannabis use
[39,40].
There are some limitations to this study relating to sam-
pling, Internet survey methodology, and the use of a proxy
measure for diagnosis. Due to recruitment through drug
policy organizations, our subjects were possibly disin-
clined to report negative symptoms related to cannabis
use. Therefore, our data may be an underestimate of true
cannabis-related symptoms, yet we were still able to dis-
cover differences between the two groups. In addition, we
saw a full range of cannabis dependence scores (0 – 8) and
a wide range of CESD scores (0 – 55; maximum score is
60) [38]. Thus, it is likely that many participants were in
fact willing to admit to negative consequences associated
with cannabis use.
Additionally, although Internet-based data collection
allows us to collect data from a nationwide sample and
from drug users who would be unwilling to travel to our
Table 3: Proportions of past year illicit drug use by dependent and non-dependent cannabis users
Illicit Drug Dependent % Reported Using Non-Dependent % Reported Using
Inhalants 10.98 4.08**
Methamphetamine 10.44 7.29**
Speed 18.45 7.63**
Cocaine 33.21 17.34**
Crack Cocaine 3.78 2.32*
Ecstasy 18.09 10.00**
Psilocybin 47.07 25.71**
LSD 15.48 9.49**
Heroin 0.99 0.90
Note. Significance determined using χ2 test with df = 1.
* p < .05 ** p < .01
Table 2: Comparison of cannabis dependent and non-dependent participants on indices of cannabis use and related problems
Index Dependent Non-Dependent
n Mean (SD) n Mean (SD) t
Joints/Week 1083 16.58 (15.18) 1743 14.14 (13.61) -4.32*
Cannabis/Month 1105 4.75 (2.09) 1764 4.18 (2.13) -7.09*
Average High 1107 4.06 (1.23) 1762 3.51 (1.28) -11.35*
Maximum High 1109 5.47 (1.03) 1763 4.95 (1.37) -11.59*
Alcohol Drinks/
Occasion
1109 4.97 (4.40) 1766 3.28 (3.64) -10.68*
Alcohol Drinks/Week 1109 11.49 (17.61) 1768 7.30 (14.22) -6.68*
Respiratory Problems 1111 1.28 (1.33) 1770 0.77 (1.12) -10.61*
Cannabis-Related 
Problems
1111 12.08 (11.00) 1770 4.21 (5.54) -22.14*
Happiness 1105 15.25 (3.71) 1756 16.23 (3.47) 7.01*
Satisfaction With Life 1109 18.92 (5.45) 1758 19.89 (5.28) 4.69*
Motivation 1092 49.60 (4.70) 1753 51.56 (4.03) 11.44*
Depression 1059 13.23 (9.69) 1700 8.45 (8.19) -13.35*
*p < .001Substance Abuse Treatment, Prevention, and Policy 2007, 2:3 http://www.substanceabusepolicy.com/content/2/1/3
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laboratory, it is unclear whether those who suffer the
worst negative consequences of drugs are willing to dis-
close all symptoms and the full extent of their drug use.
However, in a study by Wang et al. [41], students were
more likely to admit to substance use in a web-based
questionnaire than on a paper-and-pencil questionnaire.
Therefore, it is probable that participants were more will-
ing to admit to drug use, perhaps due to the remote and
anonymous nature of the Internet. Additionally, partici-
pants in this study were primarily Caucasian, male, and
relatively young, which limits the generalizability of our
results. In addition, some individuals with lower educa-
tion or socioeconomic status may not have access to the
Internet, excluding them from the study. Future research
should observe differences between dependent and non-
dependent daily cannabis users in a more diverse popula-
tion.
Use of short self-report questionnaires further limits the
conclusions that can be drawn from this study. Though
these measures were chosen due to their brevity, their sub-
jectivity in nature allows us to conclude only that canna-
bis dependent individuals view themselves as less happy
and less satisfied with life. No objective markers of quality
of life such as employment status, social roles, or activities
have been examined, and should be made a focus in
future research. Additionally, the reliability of self-report
is called into question due to the fact that many partici-
pants were long-term cannabis users. It is possible that
prolonged drug use may have produced neurophysiologi-
cal changes, resulting in errors in report. A recent report by
Degenhardt and Hall [42] has established early cannabis
use as a risk factor for later psychosis. Though this study
was not designed to assess for severe psychopathology, it
is plausible that a subset of our participants may have
experienced symptoms of psychosis, influencing the relia-
bility of our results.
We also want to stress the limitation of this study resulting
from the proxy measure of cannabis dependence. While
participants responded to questions specific to each of the
7 criteria for substance dependence, diagnostic data were
not obtained from an established method designed to
evaluate these criteria. Therefore, a definitive diagnosis of
cannabis dependence cannot be obtained. However, the
items used as a proxy for dependence strictly adhered to
the criteria in the DSM-IV-TR, so we have reason to believe
that this assessment and a structured interview would pro-
duce comparable results. In fact, it is more likely that we
have an underestimate of cannabis dependent subjects
since further probing of the subjects' responses was absent
due to the computer-based survey.
Although our data suggest a link between a proxy for can-
nabis dependence and the occurrence of various problems
and experiences, it is difficult to know whether cannabis
dependence led to, or was a result of these differences. A
study by Von Sydow, Lied, Pfister, Hofler, and Wittchen
[43] determined that cannabis dependence was best pre-
dicted by early parental death, low socio-economic status,
and additional illicit drug use. It is possible that in our
sample, past year drug use may have been a causal factor
leading to cannabis dependence, whereas the other varia-
bles could have resulted from this dependence. While the
actual direction remains unknown, there is clearly a rela-
tionship between these variables.
These results have important implications for the screen-
ing and treatment of cannabis dependence. It is important
for treatment providers to be aware of all of the potential
problems associated with cannabis dependence, as well as
the potential comorbid alcohol and drug use. Assessments
of cannabis use should be conducted in depressed per-
sons, as current or prior use of the drug may be contribut-
ing to the current mood state. In addition, cannabis users
should be made conscious of the fact that increased can-
nabis consumption is likely to produce or enhance many
problems and undesirable mood states. Education on rec-
ognition of cannabis dependence and cannabis-induced
problems is imperative in order to decrease the troubles
noted in this population. Public knowledge about the
negative effects of cannabis use may assist in motivating
treatment amongst many users who are currently resistant
or ambivalent towards change.
The notion that cannabis use in moderation may not be
problematic, especially if alcohol consumption is also
limited, might be particularly salient to those users who
recognize problems associated with cannabis use, but
who are not motivated to completely abstain. The subjects
in our study who did not meet the criteria for proxy
dependence consumed smaller quantities of both canna-
bis and alcohol, while also reporting fewer mood and
behavioral problems, even though they were daily users.
Therefore, many users may have the ability to consume
cannabis in limited quantities with few associated prob-
lems. Media campaigns relaying the message that there is
such as thing as too much cannabis use, and edifying users
about the nature of these associated problems, may assist
in directing cannabis dependent individuals toward
exploring treatment options.
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